2025国际生物医药产业创新北京论坛全体大会举行，尹力、雷海潮致辞，殷勇出席

Core Insights - The 2025 International Biopharmaceutical Industry Innovation Forum was held in Beijing, focusing on the theme "Innovation knows no borders, health shares a future" [1] Group 1: Government Initiatives and Support - The Chinese government emphasizes the advancement of pharmaceutical technology and industry development, with the 20th National Congress outlining goals for the 14th Five-Year Plan, which will inject new momentum into international health cooperation [2] - Beijing is positioned as a hub for biopharmaceutical innovation, with a vibrant industry supported by over 32 measures for high-quality development, resulting in an industry scale exceeding 1 trillion yuan [2] - Future plans include building a modern biopharmaceutical industry cluster, enhancing collaboration among universities, research institutions, hospitals, and innovative enterprises, and improving the accessibility and affordability of vaccines and new drugs [2] Group 2: Health Strategy and Market Potential - The Chinese government is advancing the "Healthy China" initiative, focusing on primary care and preventive measures, which will create vast opportunities and market potential for biopharmaceutical companies [3] - There is a commitment to fostering an open and cooperative innovation environment, encouraging biopharmaceutical enterprises to increase investment and R&D efforts in China [3] Group 3: Event Highlights and Participation - Key industry leaders, including AstraZeneca's global CEO, were present at the forum, where significant documents such as the planning scheme for the International Pharmaceutical Innovation Park were released [4] - The event was attended by various stakeholders, including government officials, industry organizations, and representatives from universities and research institutions [4]